Table:
begin	end	state
1	16	non-cytoplasmic
17	38	transmembrane
39	59	cytoplasmic
60	87	transmembrane
88	91	non-cytoplasmic
92	113	transmembrane
114	141	cytoplasmic
142	162	transmembrane
163	179	non-cytoplasmic
180	199	transmembrane
200	209	cytoplasmic
210	230	transmembrane
231	236	non-cytoplasmic
237	263	transmembrane
264	303	cytoplasmic
304	327	transmembrane
328	360	non-cytoplasmic
361	381	transmembrane
382	387	cytoplasmic
388	411	transmembrane
412	423	non-cytoplasmic
424	444	transmembrane
445	461	cytoplasmic

Input:
>WP_046009929.1 NCBI__GCF_000967895.1:WP_046009929.1
MVDIINTINGWAWGPPMLLLIAITGLFLTLGLKAYPILNIKKGFSLLWSGRKAKGEGDIS
GFNALMTSLSATIGTGNIAGVATAIAMGGPGALFWMWMIALIGMATKYSEAVLAVHYREK
DENGNFVGGPMYYIKNGLGVNWKWMATAFAFFGMIAGFGIGNGVQANSVADVMHSSFQVS
ELTTGIIMAILAALVLLGGIKRIATVAGKLVPFMAITYIIGGLILLVIYFDRIPAAFSTI
LTYAFTPASAAGGFAGASVWMAIRFGIARGVFSNEAGLGSAPIAHAAAQTNNPVQQGTIA
MLGTFIDTLVICTITGLVIVASGAWQVIDPGTGKALSGANLTAAAFSQGFPSIGGFNFGE
MIVTFGLIIFAFTTLLGWSFYGEKCAEYLFGVKSIIIFRIVWVLAIPIGATFELDLAWLV
ADTLNALMALPNLVALLLLSPVVFKLTKAAQKKSALDKEAS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server